Anti-CEA CAR-T cell therapy in CRC patients, although mediating regression of metastatic colorectal cancer, induced severe transient inflammatory colitis due to CEA expression in healthy intestinal epithelium [132]. The gene discussed is CEACAM5; the disease is metastatic colorectal cancer.